Many studies indicate that androgen-receptor pathway inhibition (ARPI) induces a cascade of changes in DNA structure, gene expression, and selective translation of proteins that regulate signaling networks to provide survival of sub-populations of prostate cancer cells15. Here, AR is linked to prostate cancer.